Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia

Br J Surg. 1984 Nov;71(11):870-3. doi: 10.1002/bjs.1800711123.

Abstract

A generalized abnormality of hypothalamopituitary function was found in 17 patients with cyclical pronounced mastalgia compared with 11 controls by using a combined thyrotrophin releasing hormone and gonadotrophin releasing hormone test. The release of prolactin, luteinizing hormone and follicle stimulating hormone was significantly greater in cyclical mastalgia patients than in controls. Basal thyrotrophin, T3 and T4 levels were within the normal range in both groups indicating normal thyroid status in benign breast disease. The single measurement of oestrogen and progesterone in the luteal phase was not abnormal. These data demonstrate an alteration in lactotroph and gonadotroph function in patients with cyclical mastalgia. It is unknown at present whether this represents an appropriate cellular response to altered central or peripheral signals. There is no evidence to suggest, however, that the anterior pituitary cell types are abnormal per se.

MeSH terms

  • Adult
  • Breast*
  • Estradiol / blood
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Hypothalamo-Hypophyseal System / physiopathology*
  • Luteinizing Hormone / blood
  • Menstrual Cycle*
  • Pain / physiopathology*
  • Pituitary Hormone-Releasing Hormones
  • Progesterone / blood
  • Prolactin / blood
  • Thyroid Hormones / blood
  • Thyrotropin-Releasing Hormone

Substances

  • Pituitary Hormone-Releasing Hormones
  • Thyroid Hormones
  • Progesterone
  • Estradiol
  • Thyrotropin-Releasing Hormone
  • Prolactin
  • Luteinizing Hormone
  • Follicle Stimulating Hormone